Our breakthrough, proprietary technology platform engineered to enhance drug absorption
End-to-end, in-house control of formulation, development, and manufacturing capabilities
Our proprietary cannabinoid composition for the management of pain and inflammation
Partnering with the world’s leading research institutions and doctors to support FDA-authorized investigator-initiated clinical trials
Learn more about cannabidiol from the medical community and regulators
We are modernizing the way medicines are taken
Experts in drug development and delivery, manufacturing, and commercialization
Recent media coverage regarding Orcosa
Company news and announcements
Dr. Graham is our Chief of Medical Affairs and a preeminent vascular surgeon with experience leading major hospital networks. Prior to Orcosa, Dr. Graham served as Chairman of Surgery at Robert Wood Johnson Medical School where he grew the division to a national leader in the treatment of patients with complex vascular pathology, and System-wide Chairman of Surgery at Crozer-Keystone Health System.
In his role as Chief of Medical Affairs, Dr. Graham defines standards for medical and scientific activities, plays a leading role in evaluating clinical benefit vs. risk, and ensures the voice of the patient is heard at the highest level of the organization. Dr. Graham graduated with his Medical Degree from Queen’s University Faculty of Health and Sciences, completed his residency with McGill University Health Centre, and his vascular fellowship with The University of Chicago.